UBS Group’s Chemours CC Stock Holding History

UBS Group’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-66,100	Closed	-$1.98M	–	8974
2023 Q1	$1.98M	Buy	+66,100	New	+$2.18M	﹤0.01%	3445
2021 Q1	–	Sell	-30,000	Closed	-$744K	–	9023
2020 Q4	$744K	Sell	30,000 -150,000	-83%	-$3.57M	﹤0.01%	4260
2020 Q3	$3.76M	Sell	180,000 -70,000	-28%	-$1.35M	﹤0.01%	2464
2020 Q2	$3.84M	Sell	250,000 -100,000	-29%	-$1.26M	﹤0.01%	2252
2020 Q1	$3.1M	Buy	+350,000	New	+$5.05M	﹤0.01%	2348

Other funds holding CC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

WHCM

Wolf Hill Capital Management Greenwich, Connecticut $1.03B AUM 80.44% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group's CC Position: Q1 2026 in Review

UBS Group reduced its Chemours (CC) stake by 23% in Q1 2026, selling an estimated $14.2M and leaving 2,767,806 shares worth $61M. The position accounts for 0.01% of the portfolio, ranked #1443.

UBS Group first reported a position in CC in Q3 2015 and has held it in 43 quarters since. The position peaked at $75.3M in Q3 2025. 448 funds tracked by Wall St. Rank hold CC as of Q1 2026.

UBS Group held 2,767,806 shares of Chemours worth $61M as of Q1 2026.
UBS Group sold 817,393 Chemours shares in Q1 2026, an estimated $14.2M.
Chemours made up 0.01% of UBS Group's portfolio in Q1 2026, its #1443 holding.
UBS Group first reported a position in Chemours in Q3 2015 and has held it in 43 quarters since.
UBS Group's Chemours position peaked at $75.3M in Q3 2025.
448 funds tracked by Wall St. Rank held Chemours as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.